Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-02-01 to 2022-02-23
Current total value of award: $8535.94
Description: 4556178801!TYSABRI 300 MG/15 ML VIAL 15ML